Opendata, web and dolomites

PODIUM SIGNED

PODIUM™ - A home device and cloud-based software and algorithm for diabetic foot ulcer monitoring

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PODIUM project word cloud

Explore the words cloud of the PODIUM project. It provides you a very rough idea of what is the project "PODIUM" about.

prevented    consequence    us    caused    grow    solution    9bn    mainly    temperature    12    risk    monitoring    global    limb    10x    suffer    cloud    introduction    threatening    amputation    foot    revealed    facilitated    extremely    decreasing    plus    liquid    deaths    treatment    uk    trade    effectiveness    23    solutions    5m    amounting    8m    percentage    subscription    sensitivity    60m    pressure    imaging    instead    thermetrix    europeans    8bn       2024    reduce    diagnosis    diabetes    thermographs    sales    validate    healthcare    market    detection    unsuccessful    cameras    considerable    model    2015    sensitive    infrared    diabetics    mortality    rate    small    complications    dfu    2025    9m    rapid    sufferers    456    podium    experiment    ulcers    ulcer    85    dramatically    75    substantial    lower    cholesteric    adults    reported    life    generating    competitive       qol    24    premature    290    physicians    5bn    quality    savings    25    diabetic    conventional    improvement    suffering    cagr    complication    serious    convenience    crystalline       roi    1m    diagnostic    amputations    450    business    efficacy    esters    dfus    lifetime   

Project "PODIUM" data sheet

The following table provides information about the project.

Coordinator
THERMETRIX LTD. 

Organization address
address: TY MENTER NAVIGATION PARK SUITE 12
city: ABERCYNON
postcode: CF45 4SN
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website https://podium.care/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2019-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    THERMETRIX LTD. UK (ABERCYNON) coordinator 50˙000.00

Map

 Project objective

'There are 60m adults suffering from diabetes in Europe and 3.8m in UK (5m by 2025). Diabetes has a high mortality rate caused mainly by complications (75,000 deaths p.a., of which 24,000 are premature). One life-threatening complication of diabetes is a diabetic foot ulcer (DFU). Studies revealed a 12% to 25% lifetime risk of developing DFU for diabetics, meaning over 9m Europeans (c.456,000 to 1m in UK) might suffer from DFU in their lifetime. A serious consequence of DFU is lower limb amputation; 85% of the amputations in diabetes sufferers are reported after unsuccessful DFU treatment amounting to 290,000–450,000 amputations/year in Europe, at a cost of €2–2.5bn/year.

The PODIUM™ technology is a novel, extremely reliable and highly sensitive solution for the cost-effective diagnosis and monitoring of DFUs through rapid temperature imaging and reliable analysis of thermographs. PODIUM™ will result in increased numbers of prevented DFUs through 10X higher sensitivity than any competitive solutions. A timely response from physicians, facilitated by PODIUM™ could reduce DFU-related amputations and healthcare costs. Thermetrix’s technology will provide a considerable Quality of Life (QoL) improvement for users and enable substantial savings in healthcare even if only a very small percentage would adopt PODIUM™. The global DFU and pressure ulcers market is expected to grow from US$2.8bn in 2015 to US$4.9bn by 2024 (CAGR 6.6%).

The objectives of this project are (1) experiment with the introduction of liquid crystalline cholesteric esters instead of infrared-cameras as detection method (dramatically decreasing the cost of the method); (2) validate the higher efficacy, diagnostic value, convenience and cost-effectiveness of PODIUM™ over conventional approaches; and (3) validate the business model based on 'unit costs plus cloud subscription' with the aim of generating a ROI of 23:1 based only on European sales only.

'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PODIUM" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PODIUM" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

DNA DS (2019)

DNA Data storage

Read More  

Keelcrab (2019)

Keelcrab the Drone for an automated hull cleaning: fast & essential

Read More  

ERGOVIAkinematix (2018)

New wearable measurement devices for Industry 4.0 based on gaming motion-capture system

Read More